06998.HK
Genor Biopharma Holdings Limited
HKSE · Healthcare · Biotechnology · CN
HKD 1.66
+0.30%Margins
Gross margin
62.6%
EBITDA margin
31.4%
EBIT margin
26.7%
Net margin
12.1%
FCF margin
11.3%
10.8%
Return on equity
7.1%
Return on assets
18.4%
Return on invested capital
0.56x
Asset turnover
HKD 527.9M
Cash from operations
HKD 0.64
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026